Market Overview:
The GCC intravenous solutions market is currently witnessing moderate growth. Intravenous (IV) solutions refer to a mix of chemically prepared fluids that are administered in the body through venous circulation. They are composed of medications and nutrients such as carbohydrates, amino acids, salts, electrolytes, vitamins, and minerals. IV solutions provide nutrients to patients suffering from cancer, diabetes, immune deficiencies, heart failure and other related diseases. In the GCC region, the demand for intravenous therapy has escalated as it offers rapid onset of drug effects compared to other drug delivery systems.
The GCC intravenous solutions market is primarily driven by the growing cases of gastrointestinal disorders, AIDS, obesity, and diabetes in the region. Apart from this, governments of several GCC countries, like Saudi Arabia, Oman and Qatar, are undertaking initiatives to offer better healthcare facilities to the people, which has increased the demand for IV solutions in the region. Besides this, the introduction of new intravenous solution products for different diseases and the treatment of dehydration is catalyzing the growth of the market. Furthermore, the faster response time and the rapid onset of drugs offered in the IV solution therapy are significant factors contributing to the market growth. Looking forward, IMARC Group expects the market to continue its moderate growth during the forecast period (2021-2026).
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the GCC intravenous solutions market report, along with forecasts for growth at the region level from 2021-2026. Our report has categorized the market based on region, type and nutrients.
Breakup by Type:
- Partial Parenteral Nutrition
- Total Parenteral Nutrition
Breakup by Nutrients:
- Carbohydrates
- Salts and Electrolytes
- Minerals
- Vitamins
- Amino Acids
Breakup by Country:
- Saudi Arabia
- UAE
- Qatar
- Oman
- Oman
- Bahrain
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
Key Questions Answered in This Report:
- How has the GCC intravenous solutions market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the GCC intravenous solutions market?
- What are the key regional markets?
- What is the breakup of the market based on the type?
- What is the breakup of the market based on the nutrients?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the GCC intravenous solutions market and who are the key players?
- What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 GCC Intravenous Solutions Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Partial Parenteral Nutrition
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Total Parenteral Nutrition
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Nutrients
7.1 Carbohydrates
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Salts and Electrolytes
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Minerals
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Vitamins
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Amino Acids
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by Country
8.1 Saudi Arabia
8.1.1 Market Trends
8.1.2 Market Breakup by Type
8.1.3 Market Breakup by Nutrients
8.1.4 Market Forecast
8.2 UAE
8.2.1 Market Trends
8.2.2 Market Breakup by Type
8.2.3 Market Breakup by Nutrients
8.2.4 Market Forecast
8.3 Qatar
8.3.1 Market Trends
8.3.2 Market Breakup by Type
8.3.3 Market Breakup by Nutrients
8.3.4 Market Forecast
8.4 Oman
8.4.1 Market Trends
8.4.2 Market Breakup by Type
8.4.3 Market Breakup by Nutrients
8.4.4 Market Forecast
8.5 Kuwait
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Bahrain
8.6.1 Market Trends
8.6.2 Market Forecast
9 SWOT Analysis
9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats
10 Value Chain Analysis
11 Porters Five Forces Analysis
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes
12 Policy and Regulatory Landscape
13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
List of Figures
Figure 1: GCC: Intravenous Solutions Market: Major Drivers and Challenges
Figure 2: GCC: Intravenous Solutions Market: Sales Value (in Million US$), 2015-2020
Figure 3: GCC: Intravenous Solutions Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 4: GCC: Intravenous Solutions Market: Breakup by Type (in %), 2020
Figure 5: GCC: Intravenous Solutions Market: Breakup by Nutrients (in %), 2020
Figure 6: GCC: Intravenous Solutions Market: Breakup by Country (in %), 2020
Figure 7: GCC: Intravenous Solutions (Partial Parenteral Nutrition) Market: Sales Value (in Million US$), 2015 & 2020
Figure 8: GCC: Intravenous Solutions (Partial Parenteral Nutrition) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 9: GCC: Intravenous Solutions (Total Parenteral Nutrition) Market: Sales Value (in Million US$), 2015 & 2020
Figure 10: GCC: Intravenous Solutions (Total Parenteral Nutrition) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 11: GCC: Intravenous Solutions (Carbohydrates) Market: Sales Value (in Million US$), 2015 & 2020
Figure 12: GCC: Intravenous Solutions (Carbohydrates) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 13: GCC: Intravenous Solutions (Salts and Electrolytes) Market: Sales Value (in Million US$), 2015 & 2020
Figure 14: GCC: Intravenous Solutions (Salts and Electrolytes) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 15: GCC: Intravenous Solutions (Minerals) Market: Sales Value (in Million US$), 2015 & 2020
Figure 16: GCC: Intravenous Solutions (Minerals) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 17: GCC: Intravenous Solutions (Vitamins) Market: Sales Value (in Million US$), 2015 & 2020
Figure 18: GCC: Intravenous Solutions (Vitamins) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 19: GCC: Intravenous Solutions (Amino Acids) Market: Sales Value (in Million US$), 2015 & 2020
Figure 20: GCC: Intravenous Solutions (Amino Acids) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 21: Saudi Arabia: Intravenous Solutions Market: Sales Value (in Million US$), 2015 & 2020
Figure 22: Saudi Arabia: Intravenous Solutions Market: Breakup by Type (in %), 2020
Figure 23: Saudi Arabia: Intravenous Solutions Market: Breakup by Nutrients (in %), 2020
Figure 24: Saudi Arabia: Intravenous Solutions Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 25: UAE: Intravenous Solutions Market: Sales Value (in Million US$), 2015 & 2020
Figure 26: UAE: Intravenous Solutions Market: Breakup by Type (in %), 2020
Figure 27: UAE: Intravenous Solutions Market: Breakup by Nutrients (in %), 2020
Figure 28: UAE: Intravenous Solutions Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 29: Qatar: Intravenous Solutions Market: Sales Value (in Million US$), 2015 & 2020
Figure 30: Qatar: Intravenous Solutions Market: Breakup by Type (in %), 2020
Figure 31: Qatar: Intravenous Solutions Market: Breakup by Nutrients (in %), 2020
Figure 32: Qatar: Intravenous Solutions Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 33: Oman: Intravenous Solutions Market: Sales Value (in Million US$), 2015 & 2020
Figure 34: Oman: Intravenous Solutions Market: Breakup by Type (in %), 2020
Figure 35: Oman: Intravenous Solutions Market: Breakup by Nutrients (in %), 2020
Figure 36: Oman: Intravenous Solutions Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 37: Kuwait: Intravenous Solutions Market: Sales Value (in Million US$), 2015 & 2020
Figure 38: Kuwait: Intravenous Solutions Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 39: Bahrain: Intravenous Solutions Market: Sales Value (in Million US$), 2015 & 2020
Figure 40: Bahrain: Intravenous Solutions Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 41: GCC: Intravenous Solutions Industry: SWOT Analysis
Figure 42: GCC: Intravenous Solutions Industry: Value Chain Analysis
Figure 43: GCC: Intravenous Solutions Industry: Porter’s Five Forces Analysis
List of Tables
Table 1: GCC: Intravenous Solutions Market: Key Industry Highlights, 2020 and 2026
Table 2: GCC: Intravenous Solutions Market Forecast: Breakup by Type (in Million US$), 2021-2026
Table 3: GCC: Intravenous Solutions Market Forecast: Breakup by Nutrients (in Million US$), 2021-2026
Table 4: GCC: Intravenous Solutions Market Forecast: Breakup by Country (in Million US$), 2021-2026
Table 5: GCC: Intravenous Solutions Market: Competitive Structure
Table 6: GCC: Intravenous Solutions Market: Key Players